M. C. Myzak, Orner, G. A., Ho, E., and Dashwood, R. H.
, “Sulforaphane suppresses tumorigenesis in Apcmin mice via inhibition of histone deacetylase”
, The Federation of American Societies for Experimental Biology
, vol. 20, no. 3, pp. 506-8, 2006.
M. C. Myzak, Tong, P., Dashwood, W. M., Dashwood, R. H., and Ho, E.
, “Sulforaphane retards the growth of human PC-3 prostate cancer xenografts and inhibits HDAC activity in human subjects”
, Experimental Biology and Medics
, vol. 232, no. 2, pp. 227-234, 2007.
M. C. Myzak, Hardin, K., Dashwood, R. H., and Ho, E.
, “Sulforaphane Inhibits Histone Deacetylase Activity in BPH-1, LnCaP, and PC-3 Prostate Epithelial Cells”
, vol. 27, no. 4, pp. 811-819, 2006.
R. H. Dashwood, Myzak, M. C., and Ho, E.
, “Dietary HDAC inhibitors: Time to rethink weak ligands for cancer prevention”
, vol. 27, no. 2, pp. 344-9, 2006.
M. C. Myzak, Ho, E., and Dashwood, R. D.
, “Dietary agents as histone deacetylase inhibitors”
, Molecular Carcinogenesis
, vol. 45, no. 6, pp. 443-446, 2006.